Psoriasis and dyslipidaemia: a population-based study.

Previous reports demonstrated an association between psoriasis and the metabolic syndrome. The aim of this study was to elucidate the association between psoriasis and dyslipidaemia. A cross-sectional study was performed utilizing a population-based database. Psoriasis patients were compared with enrollees without psoriasis regarding the prevalence of dyslipidaemia and lipid levels. Comparison of lipid levels was performed on a "low-risk" subset of subjects without diabetes, hypertension and cardiovascular disease. The study included 10,669 psoriasis patients and 22,996 subjects without psoriasis. The prevalence of dyslipidaemia was significantly higher in psoriasis patients (odds ratio (OR) = 1.48, 95% confidence interval (CI) 1.40-1.55). The association remained significant after controlling for confounders (OR = 1.19, 95% CI 1.12-1.26, p < 0.001). In multivariate analysis of the "low-risk" subset, triglyceride levels were higher in psoriasis patients and high-density lipoprotein cholesterol levels were lower. This study supports previous reports of an association between psoriasis and lipid abnormalities.

[1]  A. Pietrzak,et al.  Activity of serum lipase [EC 3.1.1.3] and the diversity of serum lipid profile in psoriasis. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[2]  S. Vinker,et al.  Usefulness of electronic databases for the detection of unrecognized diabetic patients , 2003, Cardiovascular diabetology.

[3]  E. Christophers,et al.  Disease concomitance in psoriasis. , 1995, Journal of the American Academy of Dermatology.

[4]  G. Ekuklu,et al.  Serum lipid levels in psoriasis. , 2003, Yonsei medical journal.

[5]  J. Meyerovitch,et al.  Psoriasis and diabetes: a population‐based cross‐sectional study , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  N. Tekin,et al.  Accumulation of Oxidized Low-Density Lipoprotein in Psoriatic Skin and Changes of Plasma Lipid Levels in Psoriatic Patients , 2006, Mediators of inflammation.

[7]  S. Feldman,et al.  The comorbid state of psoriasis patients in a university dermatology practice , 2005, The Journal of dermatological treatment.

[8]  C. Griffiths,et al.  Psoriasis: epidemiology, clinical features, and quality of life , 2005, Annals of the rheumatic diseases.

[9]  E. Martínez-Abundis,et al.  Lipid profile, insulin secretion, and insulin sensitivity in psoriasis. , 2003, Journal of the American Academy of Dermatology.

[10]  B. Vessby,et al.  Serum lipoproteins in middle-aged men with psoriasis. , 1987, Acta dermato-venereologica.

[11]  L. Naldi,et al.  Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. , 2005, The Journal of investigative dermatology.

[12]  E. Sijbrands,et al.  Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. , 2007, Atherosclerosis.

[13]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[14]  Anna Viner,et al.  The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. , 2007, Journal of the American Academy of Dermatology.

[15]  M. Weichenthal,et al.  Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis , 2006, Archives of Dermatological Research.

[16]  C. Ritchlin,et al.  Metabolic disorders in patients with psoriasis and psoriatic arthritis , 2006, Current rheumatology reports.

[17]  A. Orem,et al.  Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[18]  G. Rennert,et al.  Prevalence of selected chronic diseases in Israel. , 2001, The Israel Medical Association journal : IMAJ.

[19]  B. Gersh.  Risk of Myocardial Infarction in Patients With Psoriasis , 2007 .

[20]  F. Granath,et al.  Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients , 2003, European Journal of Epidemiology.

[21]  A. Hamsten,et al.  Psoriasis is associated with lipid abnormalities at the onset of skin disease. , 2006, Journal of the American Academy of Dermatology.

[22]  I. Rebelo,et al.  Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[23]  Daniel B. Shin,et al.  Prevalence of cardiovascular risk factors in patients with psoriasis. , 2022, Central European journal of public health.

[24]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[25]  E. Christophers.  Comorbidities in psoriasis , 2006 .